Genomics & Omics Analysis - software & AI news

Daily news on software, AI, and companies shaping genomics & omics analysis.

Showing 121 results
Press release cover image

Aug 31, 2026

Probably Genetic Awarded Up to $10M ARPA-H Contract to End the Rare Disease Diagnostic Odyssey with AI

Part of the RAPID program, Probably Genetic will scale patient-driven AI platform to accelerate rare disease diagnosis, research, and treatmentSAN FRANCISCO, Aug. 31, 2026 /PRNewswire/ -- Probably Genetic, the AI platform powering the research, diagnosis, and treatment of genetic diseases, has been awarded up to $10 million from the Advanced Research Projects Agency for Health (ARPA-H), a U.S. federal agency within the Department of Health and Human Services (HHS) that funds high-risk, high-rewa
Press release cover image

Aug 31, 2026

New genomics collaboration to enable First Nations sovereignty over salmon data

VANCOUVER, British Columbia, Aug. 31, 2026 (GLOBE NEWSWIRE) -- A new multi-year, multi-partner collaboration aims to empower First Nations communities in British Columbia with salmon genetic analysis tools, technology, infrastructure and skills for fisheries management. The project has secured funding for the next three years from the First Nations Fisheries Council’s Indigenous Stewardship Fund, the Pacific Salmon Foundation and Genome British Columbia. Candace Picco (Senior Biologist, Ha’oom
Flat illustration of an electronic health record with a data stream

Aug 31, 2026

The next frontier: Advancing foundation models with multimodal data

Researchers are advancing AI capabilities in health by integrating electronic health records (EHR) with genomic data, aiming to enhance disease prediction and personalize care.The collaboration between Verily Health, NVIDIA, and the NIH's All of Us Research Program has led to the development of a groundbreaking multimodal foundation model. This model merges EHR and genomic data, showcasing the potential to create a more comprehensive understanding of health and improve precision medicine. By com
Press release cover image

Aug 26, 2026

PrecisionLife Selects Gencove as US Partner to Launch and Deliver DNA Wellness Reports

Partnership provides US-based sequencing and scalable consumer genomics infrastructure, including an at-home DNA collection, to deliver PrecisionLife's personalized wellness reports to US consumers OXFORD, England and NEW YORK, Aug. 26, 2026 /PRNewswire/ -- PrecisionLife, an AI-led health and life sciences company applying advanced analytics to complex chronic disease research, has selected Gencove as its consumer genetics platform partner to launch its DNA wellness reports in the United States.
Press release cover image

Aug 26, 2026

DarwinHealth Introduces Quantum Cancer Biology: A Cell-State Systems Biology Framework for Precision Oncology

New paradigm integrates single-cell transcriptomics, regulatory network inference, and AI to decode—and therapeutically target—the multiple, co-existing cancer cell states that drive resistance in pancreatic cancer, glioblastoma, and other lethal malignanciesNEW YORK, Aug. 26, 2026 /PRNewswire/ -- DarwinHealth, a New York-based, AI-centric biotechnology company. today announced the introduction of Quantum Cancer Biology: A Cell-State Systems Biology Framework for Precision Oncology, a transforma
Press release cover image

Aug 25, 2026

Stowers scientists develop a new way to visualize what AI models learn from DNA -- and discover how to control what the models learn next

The AI model interpretation method, PISA, shows what genomic AI models learn, allowing scientists to separate experimental bias from biology, train more focused models, and uncover unexpected insights related to gene regulation and genetic disease.What's new, and why it matters:PISA (pairwise influence by sequence attribution) is a new method that traces a deep-learning model's prediction at any single DNA base back to every other base that influenced it, producing a base-pair-resolution map of
Press release cover image

Aug 25, 2026

Stowers Institute expands Artificial Intelligence Initiative, appoints second AI Fellow

Charles McAnany, Ph.D., uses machine learning to uncover hidden patterns in DNA and better understand how genes are regulated. As an AI Fellow, he will help expand the use of AI across the Institute's 24 research programs.KANSAS CITY, Mo., Aug. 25, 2026 /PRNewswire/ -- The Stowers Institute for Medical Research has appointed Charles McAnany, Ph.D., as its second AI Fellow, continuing the Institute's investment in artificial intelligence as a powerful tool for advancing biological discovery.Conti
Press release cover image

Aug 24, 2026

GeneDx Announces Transformative Study Supporting Hospital-Wide Adoption of Rapid Genomic Sequencing at Seattle Children’s

Published in Genetics in Medicine, study shows broad inpatient implementation of rapid genome sequencing significantly increased diagnostic rates and reduced time to diagnosisChildren experiencing faltering growth saw striking 63% diagnostic yieldGAITHERSBURG, Md.--(BUSINESS WIRE)--GeneDx (Nasdaq: WGS), the leader in rare disease diagnosis and improving health through the power of genomic data, today announced new data published in Genetics in Medicine, an official journal of the American Colleg
A flat illustration of a tissue sample and genomic data strands in a minimalist style.

Aug 21, 2026

Bioptimus, Cancer Research Horizons partner on AI-powered precision medicine

Bioptimus, a Paris-based AI biotech firm, has partnered with Cancer Research Horizons to enhance AI-driven precision medicine through access to extensive colorectal cancer datasets.The collaboration grants Bioptimus access to the S:CORT dataset, which encompasses over 1,750 patient profiles and integrates multiple data modalities, including imaging and genomic information. This resource is part of Bioptimus's broader initiative, STELA, aimed at constructing a comprehensive multimodal tissue atla
A tissue sample in a lab setting

Aug 19, 2026

$50m Network Bio launch & NVIDIA collaboration

Palo Alto's Network Bio has launched with $50 million in funding and a groundbreaking partnership with NVIDIA to develop a foundation model utilizing cell-free RNA data.Network Bio has established a robust research network by collaborating with prominent academic biobanks across the United States, including institutions like Mass General Brigham and the University of Pennsylvania. This network grants access to a vast dataset comprising over 500,000 patients, focusing on various health domains su
Press release cover image

Aug 18, 2026

Craif Raises $33M to Accelerate Introduction of Its Urine-Based Cancer Test to the U.S.

SAN DIEGO, Aug. 18, 2026 (GLOBE NEWSWIRE) -- Craif Inc., a bio-AI company developing a urine analysis platform for early detection of cancer and other diseases, today announced the close of its approximately $33 million* Series D, bringing total capital raised since the company's founding to roughly $88 million**. Craif will use the proceeds to strengthen its U.S. R&D, prepare for a reimbursement-driven launch of its non-invasive cancer test in the United States and advance its Japanese re
A DNA sample in a vial on a lab bench with a microscope in the background.

Aug 13, 2026

Human Longevity Launches $600 Whole Genome

Human Longevity has unveiled a new product, Genomics for All, which offers whole genome sequencing at a competitive price of $599, aiming to democratize access to genomic information.This new service provides comprehensive sequencing of an individual's entire genome, covering 6.4 billion base pairs at a clinical-grade depth of 30x. It identifies inherited disease risks linked to over 10,000 genetic variants and highlights pharmacogenomic markers that inform how individuals might respond to medic